Inspired by Nature.
Empowered by Technology.
Committed to Life.
Advancing Human-Relevant Systems to Reduce Reliance on Animal Models
Integrated • Predictive • Translational
Accelerating Smarter, More Human-Relevant Medicine
Human-Relevant Programs
A growing portfolio of integrated NAM-aligned workflows for disease modeling, therapeutic response, and translational decision-making.
NAMina Bio’s Human-Relevant Programs are designed to translate advanced in vitro biology, dynamic physiological systems, multi-omics, bioinformatics, and AI-enabled interpretation into structured workflows that support more predictive preclinical decision-making.
Our initial program portfolio focuses on cancer resistance, dynamic exposure modeling, and metabolic risk profiling, with future expansion across additional disease contexts and translational applications.
A Portfolio Designed to Expand NAMina Bio’s Human-Relevant Programs are built on a shared translational architecture.
Each program begins with a defined biological or translational question and integrates the most appropriate model systems, dynamic culture conditions, functional readouts, omics, bioinformatics, and interpretation strategy.
This approach allows NAMina Bio to launch focused programs today while building a scalable framework that can expand across oncology, metabolism, gene delivery, immuno-oncology, hypoxia biology, barrier physiology, and future disease areas.
Our goal is to support researchers, biotech companies, and translational teams with workflows that generate more human-relevant, decision-ready evidence.
A Common Translational Architecture Across Programs
Although each program addresses a different biological question, NAMina Bio applies a common integration framework:
Human-relevant biological model
Advanced 3D, patient-derived, tissue-like, or disease-relevant systems.
Dynamic and functional context
Flow, perfusion, exposure gradients, oxygen control, barrier modeling, repeated dosing, or physiologically relevant stressors.
Multi-modal readouts
Drug response, imaging, viability, functional behavior, transcriptomics, single-cell analysis, and pathway-level interpretation.
Decision-read outputs
Structured reporting designed to support candidate prioritization, mechanism exploration, assay development, and translational planning.
Explore Our Programs
Mature Tumoroid Resistance Profiling™
3D tumor maturation, hidden resistance phenotypes, and drug response profiling.
The Mature Tumoroid Resistance Profiling™ program is designed to reveal therapeutic response patterns that may be missed in conventional 2D or early 3D systems. By incorporating tumor maturation, matrix context, and functional response analysis, this workflow supports more biologically meaningful evaluation of drug sensitivity, resistance, and treatment adaptation.
This program is particularly relevant for oncology teams seeking to evaluate candidate therapies, combinations, or resistance mechanisms in more human-relevant 3D tumor contexts.
Dynamic Systems & Fluidic Platforms
Flow, perfusion, oxygen gradients, barrier dynamics, and repeated exposure modeling.
The Dynamic Systems program integrates fluidic and microphysiological platforms to move beyond static culture conditions. These workflows are designed to better capture how tissues experience drugs over time, including exposure dynamics, transport, barrier interaction, perfusion, oxygen gradients, and repeated dosing effects.
This program supports translational questions where static assays may not fully reflect physiological exposure, tissue interaction, or dynamic response.
Metabolic Syndrome & Klotho Modulation
AI-enabled metabolic risk profiling and systems-level translational interpretation.
The Metabolic Syndrome & Klotho Modulation program expands NAMina Bio’s human-relevant approach into data-driven disease modeling and biological risk interpretation.
This program integrates real-world data, metabolic biomarkers, computational analysis, and biological simulation concepts to explore disease risk, pathway modulation, and translational intervention strategies.
This program is designed to support future applications in metabolic health, aging biology, preventive medicine, biomarker discovery, and AI-enabled translational modeling.
